Carl E. Clarke

Dudley Road
Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.

Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.

Journal: NPJ Parkinson's disease

Published: January 20, 2026

Genome-wide association study of copy number variations in Parkinson's disease.

Genome-wide association study of copy number variations in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: August 24, 2025

The PD COMM Process Evaluation: Describing Interventions and Implementation in a UK Pragmatic Randomised Controlled Trial of Speech and Language Therapy for People With Parkinson's-Related Dysarthria.

The PD COMM Process Evaluation: Describing Interventions and Implementation in a UK Pragmatic Randomised Controlled Trial of Speech and Language Therapy for People With Parkinson's-Related Dysarthria.

Journal: International journal of language & communication disorders

Published: December 12, 2024

The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.

The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.

Journal: Health technology assessment (Winchester, England)

Published: October 04, 2024

Genome-wide association study of copy number variations in Parkinson's disease.

Genome-wide association study of copy number variations in Parkinson's disease.

Journal: medRxiv : the preprint server for health sciences

Published: September 04, 2024

Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.

Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.

Journal: BMJ (Clinical research ed.)

Published: July 10, 2024

Association of Body Mass Index and Parkinson Disease: A Bidirectional Mendelian Randomization Study.

Association of Body Mass Index and Parkinson Disease: A Bidirectional Mendelian Randomization Study.

Journal: Neurology

Published: July 10, 2024

Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert Panel.

Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert Panel.

Journal: Journal of Parkinson's disease

Published: January 13, 2024

Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers.

Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: September 26, 2022

Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease-Reply.

Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease-Reply.

Journal: JAMA neurology

Published: June 27, 2022

The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited.

The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: February 21, 2022

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.

Journal: JAMA neurology

Published: December 28, 2021

Showing 1-12 of 89

Last Updated: 09/26/2026